Type I Gaucher Disease Following Chemotherapy for Light Chain Multiple Myeloma

Internal Medicine - Japan
doi 10.2169/internalmedicine.46.6243
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Gaucher Disease Type I Complicated With Parkinson's Syndrome

Haematologia
2002English

Clinical Characteristics and Prognostic Factors in Multiple Myeloma Patients With Light Chain Deposition Disease

American Journal of Hematology
Hematology
2017English

Multiple Glycosidase Deficiencies in a Case of Juvenile (Type 3) Gaucher Disease.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1978English

Genetic Predisposition for Chemotherapy-Induced Neuropathy in Multiple Myeloma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Monitoring of Light Chain Myeloma - Time for a Change

British Journal of Haematology
Hematology
2017English

VCAP Combination Chemotherapy for Multiple Myeloma in the Aged.

Japanese Journal of Geriatrics
GerontologyGeriatrics
1991English

Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I

2019English

Diagnosis and Monitoring for Light Chain Only and Oligosecretory Myeloma Using Serum Free Light Chain Tests

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2017English

Single-Agent Thalidomide for Treatment of First Relapse Following High-Dose Chemotherapy in Patients With Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy